Inhalation Sciences receives IRS order worth 1.9 million SEK with US pharma company
Inhalation Sciences AB (ISAB) has received an order worth 1.9 MSEK (178,000 Euros) for an Inhalation Research Service (IRS) project with a mid-sized US pharma company. The project will use ISAB’s leading in vitro dissolution and absorption module DissolvIt[®][ ]to test the dissolution profiles of a new inhaled drug.The project will test the dissolution profiles of a new drug with several formulations, both with and without excipients. It will also test if the drug’s dissolution properties are maintained when scaling up production. ISAB’s in vitro dissolution technology - DissolvIt[® ]-